Financials

  • Market Capitalization 24.79 B
  • Employee 100
  • Founded 1996
  • CEO N/A
  • Website www.royaltypharma.com
  • Headquarter United Kingdom
  • FIGI N/A
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
25.25
Price to sales ratio
11.02
Dividends per share
0.23
Dividend yield %
4.62

News